Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT05702502
Eligibility Criteria:
Inclusion criteria:
* Informed consent.
* Age ≥18 years.
* Clinically confirmed HLH.
* High dose steroids and/or systemic anti-cancer therapy (SACT) for \<72 hours for the current episode of HLH (anakinra is not considered SACT). Prior steroid use \>14 days at the time of consent is permitted.
* Patients with recurrent HLH may be included.
* Patients already known to have underlying lymphoma, or have relapsed lymphoma may be included.
Exclusion criteria:
• Cause of HLH already known to be due to a non-malignant cause.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05702502
Study Brief:
Protocol Section:
NCT05702502